A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study

Ruyan Wu,1,* Dandan Zhu,1,* Youchun Xia,2,* Haosen Wang,2 Weiwei Tao,1 Wenda Xue,1 Baomei Xia,1 Li Ren,1 Xin Zhou,1 Guochun Li,3 Gang Chen1 1Center for Translational Systems Biology and Neuroscience, Key Laboratory of Integrative Biomedicine of Brain Diseases, Nanjing University of Chinese Medicine...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wu R, Zhu D, Xia Y, Wang H, Tao W, Xue W, Xia B, Ren L, Zhou X, Li GC, Chen G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/2611cbac416d4f958f4469c1111a389d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2611cbac416d4f958f4469c1111a389d
record_format	dspace
spelling	oai:doaj.org-article:2611cbac416d4f958f4469c1111a389d2021-12-02T00:27:19ZA role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study1178-2021https://doaj.org/article/2611cbac416d4f958f4469c1111a389d2015-08-01T00:00:00Zhttp://www.dovepress.com/a-role-of-yueju-in-fast-onset-antidepressant-action-on-major-depressiv-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Ruyan Wu,1,* Dandan Zhu,1,* Youchun Xia,2,* Haosen Wang,2 Weiwei Tao,1 Wenda Xue,1 Baomei Xia,1 Li Ren,1 Xin Zhou,1 Guochun Li,3 Gang Chen1 1Center for Translational Systems Biology and Neuroscience, Key Laboratory of Integrative Biomedicine of Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China; 2The Fourth People’s Hospital of Taizhou, Taizhou, People’s Republic of China; 3School of Basic Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China *These authors contributed equally to this work Introduction: Conventional antidepressants, including fluoxetine, have a major disadvantage in delayed onset of efficacy. Yueju, an herbal medicine used to treat mood disorders was recently found to exhibit rapid antidepressant effects. The present study was conducted to evaluate the role of Yueju in rapidly acting on major depressive disorder (MDD).Methods: Participants were MDD patients with scores of 24-item Hamilton Depression Rating Scale (HDRS-24) ≥20 and without history of antidepressant use. They randomly received daily oral doses of Yueju (23 g/day) plus fluoxetine (20 mg/day) (experimental group) or placebo plus fluoxetine (control group) for 7 days. HDRS-24 was used as the primary outcome measurement at baseline, and on days 1, 3, 5, and 7. Concentrations of serum brain-derived neurotrophic factor (BDNF) were assessed at baseline and on days 1 and 7.Results: In all, 18 participants met the criteria for data analysis. Compared to baseline level, only experimental group showed significant decrease of HDRS-24 score from day 3 to day 7 (P<0.05). Experimental group also showed significant improvement compared with control group from day 3 to day 7 (P<0.05). No correlation between treatment outcomes with serum BDNF levels was observed. However, experimental group showed significant correlation for serum BDNF level on day 1 with day 7 (r=0.721, P=0.028), whereas the control group did not.Conclusion: Yueju likely contributes to fast-onset antidepressant effects on MDD. Further investigation is necessary to firmly establish the ancient formula as a safe, efficacious, and rapidly acting alternative medicine for MDD treatment. Keywords: Yueju, major depressive disorder, HDRS-24, MADRS, rapid-onset, BDNFWu RZhu DXia YWang HTao WXue WXia BRen LZhou XLi GCChen GDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 2013-2021 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Wu R Zhu D Xia Y Wang H Tao W Xue W Xia B Ren L Zhou X Li GC Chen G A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study
description	Ruyan Wu,1,* Dandan Zhu,1,* Youchun Xia,2,* Haosen Wang,2 Weiwei Tao,1 Wenda Xue,1 Baomei Xia,1 Li Ren,1 Xin Zhou,1 Guochun Li,3 Gang Chen1 1Center for Translational Systems Biology and Neuroscience, Key Laboratory of Integrative Biomedicine of Brain Diseases, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China; 2The Fourth People’s Hospital of Taizhou, Taizhou, People’s Republic of China; 3School of Basic Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China *These authors contributed equally to this work Introduction: Conventional antidepressants, including fluoxetine, have a major disadvantage in delayed onset of efficacy. Yueju, an herbal medicine used to treat mood disorders was recently found to exhibit rapid antidepressant effects. The present study was conducted to evaluate the role of Yueju in rapidly acting on major depressive disorder (MDD).Methods: Participants were MDD patients with scores of 24-item Hamilton Depression Rating Scale (HDRS-24) ≥20 and without history of antidepressant use. They randomly received daily oral doses of Yueju (23 g/day) plus fluoxetine (20 mg/day) (experimental group) or placebo plus fluoxetine (control group) for 7 days. HDRS-24 was used as the primary outcome measurement at baseline, and on days 1, 3, 5, and 7. Concentrations of serum brain-derived neurotrophic factor (BDNF) were assessed at baseline and on days 1 and 7.Results: In all, 18 participants met the criteria for data analysis. Compared to baseline level, only experimental group showed significant decrease of HDRS-24 score from day 3 to day 7 (P<0.05). Experimental group also showed significant improvement compared with control group from day 3 to day 7 (P<0.05). No correlation between treatment outcomes with serum BDNF levels was observed. However, experimental group showed significant correlation for serum BDNF level on day 1 with day 7 (r=0.721, P=0.028), whereas the control group did not.Conclusion: Yueju likely contributes to fast-onset antidepressant effects on MDD. Further investigation is necessary to firmly establish the ancient formula as a safe, efficacious, and rapidly acting alternative medicine for MDD treatment. Keywords: Yueju, major depressive disorder, HDRS-24, MADRS, rapid-onset, BDNF
format	article
author	Wu R Zhu D Xia Y Wang H Tao W Xue W Xia B Ren L Zhou X Li GC Chen G
author_facet	Wu R Zhu D Xia Y Wang H Tao W Xue W Xia B Ren L Zhou X Li GC Chen G
author_sort	Wu R
title	A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study
title_short	A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study
title_full	A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study
title_fullStr	A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study
title_full_unstemmed	A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study
title_sort	role of yueju in fast-onset antidepressant action on major depressive disorder and serum bdnf expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/2611cbac416d4f958f4469c1111a389d
work_keys_str_mv	AT wur aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT zhud aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT xiay aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT wangh aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT taow aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT xuew aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT xiab aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT renl aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT zhoux aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT ligc aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT cheng aroleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT wur roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT zhud roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT xiay roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT wangh roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT taow roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT xuew roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT xiab roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT renl roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT zhoux roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT ligc roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy AT cheng roleofyuejuinfastonsetantidepressantactiononmajordepressivedisorderandserumbdnfexpressionarandomlydoubleblindfluoxetineadjunctplacebocontrolledpilotclinicalstudy
_version_	1718403728842686464

A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study

Ejemplares similares